US00650F1093
US00650F1093
Adaptive Biotechnologies Corpor
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 276.976.000 | 178.957.000 | 54.8% |
| Cost of Revenue | 71.359.000 | 72.080.000 | 1.0% |
| Gross Profit | 205.617.000 | 106.877.000 | 92.4% |
| 262.740.000 | 262.221.000 | 0.2% | |
| Operating Income | -57.123.000 | -155.344.000 | 63.2% |
| Pretax Income | -59.457.000 | -159.595.000 | 62.7% |
| Net Income Common Stockholders | -59.499.000 | -159.492.000 | 62.7% |
| -- | -- | -- | |
| -- | -- | -- |